Crossmark

Effectiveness of Certolizumab Pegol in the Treatment of Psoriasis in a Cohort of Patients With Psoriatic Arthritis

Published Print: 2020-10

Authors

Reina, D.

Vidal, D.
Funding

Funding for this research was provided by:

UCB Pharma
License Information

Text and Data Mining valid from 2020-10-01

Version of Record valid from 2020-09-18
More Information

This article is maintained by: Elsevier

Article Title: Effectiveness of Certolizumab Pegol in the Treatment of Psoriasis in a Cohort of Patients With Psoriatic Arthritis

Journal Title: Actas Dermo-Sifiliográficas (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.adengl.2019.01.025

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.ad.2019.01.023

Content Type: simple-article

Copyright: © 2020 AEDV. Published by Elsevier España, S.L.U.

Document is current